Skip to content

Controversial Reversal? Let’s Talk DOACs

Live Online Webinar Hosted Using Zoom version 5.9.1.
Thursday, June 9, 2022 | 2:00 PM - 3:00 PM EST

This activity is intended for ambulatory care pharmacists who work with patients prescribed direct oral anticoagulants (DOACs).

At the completion of this activity, the participant will be able to:

  • Explain the mechanism of action of DOAC reversal agents
  • Identify contraindications for therapy with reversal agents
  • Describe key points published within current literature to support recommendations for reversal agents
  • Construct a treatment plan for DOAC reversal patients in patients presenting with a major bleed

Presenter

Jennifer Hammond, PharmD, is a PGY1 pharmacy resident at Baystate Medical Center in Springfield, Massachusetts. She obtained her Doctor of Pharmacy degree in May 2021 from the University of New England School of Pharmacy in Portland, Maine. Jennifer’s practice interests include critical care and emergency medicine.

There is no fee to attend this activity. Registration is required to earn ACPE credit.

Register


Universal Activity Number: 0026-0000-22-130-H01-P | knowledge-based
Topic Designator: Drug Therapy
Contact Hours: 1 (0. 1 CEU)

Accreditation

ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1 contact hour (0.1 CEUs).

 

Requirements for Credit

Partial credit will not be awarded. To claim credit participants must log into their profile on MCPHS CE portal and insert the specific activity code for this webinar in order to access and complete the evaluation. CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours. Attendance will be verified. Credit will not be issued to participants who join the meeting more than 15 minutes after the start of the meeting or to those who depart early. Credit cannot be awarded to individuals who complete the activity evaluation more than 60 days post activity.

Evaluation

All participants will have the opportunity to review the educational session and speakers, and to identify future educational needs.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Jennifer Hammond has no financial relationships with ineligible companies. Off-label/investigational uses of Prothrombin Complex Concentrate (human) will be discussed.

Frank Szcerba has no financial relationships with ineligible companies.

All CE staff members have no relevant financial relationships with ineligible companies to disclose.

No funding from industry provided for this event. No exhibitors will be present.